NASDAQ:SLN

Silence Therapeutics

Stock

USD

Last Close

540.00

24/04 19:47

Volume Today

913.53K

Avg: 65.78K

PE Ratio

−14.72

PFCF: −14.65

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '22	Dec '23	Dec '24
revenue	15K -		770K -	16K 97.92%		244K -	5.48M 2,145.49%	17.50M 219.42%	25.38M 44.99%	43.26M 70.47%
cost of revenue	8.88M -	7.11M 19.92%					3.76M -	10.88M 189.21%	10.32M 5.17%	11.81M 14.46%
gross profit	-8.87M -	-7.11M 19.79%	770K 110.82%	16K 97.92%		244K -	1.72M 603.69%	6.62M 285.61%	15.06M 127.41%	31.45M 108.86%
selling and marketing expenses
general and administrative expenses	3.26M -	2.65M 18.51%	3.96M 49.34%	6.46M 63.03%	10.83M 67.51%	9.64M 10.95%	13.98M 45.02%	19.61M 40.23%	20.64M 5.24%	26.88M 30.28%
selling general and administrative expenses	3.26M -	2.65M 18.51%	3.96M 49.34%	6.46M 63.03%	10.83M 67.51%	9.64M 10.95%	13.98M 45.02%	19.61M 40.23%	20.64M 5.24%	26.88M 30.28%
research and development expenses	8.88M -	7.11M 19.92%	8.71M 22.45%	7.94M 8.82%	9.74M 22.66%	13.34M 36.88%	20.21M 51.54%	35.60M 76.18%	44.02M 23.65%	67.88M 54.19%
other expenses
cost and expenses	21.03M -	16.88M 19.70%	12.68M 24.92%	14.41M 13.66%	20.57M 42.78%	22.98M 11.70%	37.95M 65.18%	66.09M 74.14%	74.98M 13.44%	106.58M 42.14%
operating expenses	12.14M -	9.77M 19.54%	12.68M 29.76%	14.41M 13.66%	20.57M 42.78%	22.98M 11.70%	34.19M 48.80%	55.21M 61.48%	64.66M 17.11%	94.77M 46.56%
interest expense				15K -		33K -	16K 51.52%	47K 193.75%	34K 27.66%
ebitda	-11.65M -	-9.25M 20.61%	-10.05M 8.71%	-3.33M 66.90%	-20.13M 504.96%	-22.36M 11.07%	-35.60M 59.24%	-47.88M 34.52%	-49.78M 3.95%	-48.99M 1.59%
operating income	-11.98M -	-9.43M 21.29%	-10.36M 9.90%	-3.76M 63.71%	-20.53M 445.90%	-22.84M 11.26%	-36.02M 57.75%	-48.59M 34.89%	-49.60M 2.08%	-63.32M 27.65%
depreciation and amortization	332K -	182K 45.18%	310K 70.33%	433K 39.68%	399K 7.85%	482K 20.80%	428K 11.20%	482K 12.62%	498K 3.32%	593K 19.08%
total other income expenses net				-15K -		-33K -	-16K 51.52%	1.23M 7,756.25%	-706K 157.63%	18.86M 2,770.68%
income before tax	-11.98M -	-9.43M 21.29%	-10.36M 9.90%	-3.77M 63.57%	-20.53M 443.74%	-22.87M 11.42%	-36.04M 57.59%	-47.37M 31.43%	-50.31M 6.21%	-44.46M 11.62%
income tax expense	-892K -	-2.78M 212.11%	-1.92M 30.96%	-2.16M 12.23%	-2.12M 1.95%	-3.29M 55.46%	-3.49M 6.27%	-6.88M 96.88%	-7.04M 2.38%	845K 112.00%
net income	-11.09M -	-6.64M 40.07%	-8.44M 27.01%	-1.62M 80.83%	-18.41M 1,037.89%	-19.58M 6.36%	-32.55M 66.21%	-40.49M 24.40%	-43.27M 6.86%	-45.31M 4.72%
weighted average shs out	50.42M -	64.02M 26.97%	69.80M 9.02%	69.94M 0.20%	70.31M 0.53%	75.13M 6.85%	81.78M 8.85%	32.19M 60.63%	37.09M 15.21%	47.22M 27.32%
weighted average shs out dil	50.42M -	64.02M 26.97%	69.80M 9.02%	69.94M 0.20%	70.31M 0.53%	75.13M 6.85%	81.78M 8.85%	32.19M 60.63%	37.09M 15.21%	47.22M 27.32%
eps	-0.22 -	-0.10 54.55%	-0.12 20.00%	-0.02 80.75%	-0.26 1,025.54%	-0.26 0%	-0.40 53.85%	-1.26 215%	-1.17 7.14%	-0.98 16.24%
epsdiluted	-0.22 -	-0.10 54.55%	-0.12 20.00%	-0.02 80.75%	-0.26 1,025.54%	-0.26 0%	-0.40 53.85%	-1.26 215%	-1.17 7.14%	-0.98 16.24%

All numbers in USD (except ratios and percentages)